News
Observing World Asthma Month Every Day in May
There are many organizations providing opportunities for the May 2, 2023 observance of World Asthma Day and World Asthma Month, which is in May each year.
Severe Asthma Clinical Practice Course at ATS 2023
What are the latest recommendations for the management of severe asthma? See details about a post-graduate course being offered at ATS 2023.
Moderate to Severe Asthma: A Podcast Series
A limited podcast series is now available that takes a deep dive into the diagnosis, treatment, and ongoing care of patients with moderate to severe asthma. Produced by Medscape, the “InDiscussion: Moderate to Severe Asthma” podcast series is an in-depth interview style-look at the field of asthma.
Severe Asthma
The PrecISE Clinical Trial, Time Commitment, New Type of Asthma Study, Compensation, Enroll.
Publications Update - The Study's Design
Latest publications - see the list here.
American Thoracic Society and PrecISE Present Webinar on Severe Asthma for World Asthma Day
The webinar will be held on May 5 from 12-1pm EDT and coincides with this year’s annual observance of World Asthma Day. Register to attend.
Why PrecISE - Better ways to treat severe asthma - Watch the video
PrecISE is a network looking for better ways to treat teens and adults with severe asthma - learn more in this video.
PrecISE Co-Investigator Honored as “Hero Doc” by New York Post
Dr. Michael Peters is a west-coast based physician and researcher at the University of California – San Francisco (UCSF). He sees asthma patients there at the Severe Asthma Clinic and is an attending at the UCSF Critical Care Unit.
A native of New York, Dr. Peters’ thoughts turned to home as the medical response to the coronavirus intensified in New York.
COVID-19 Response and the PrecISE Research Study
Safety is our number one priority, for patients, their families, and our team members who work on all aspects of PrecISE.
Recruitment and Screening for PrecISE Clinical Study Opens
The PrecISE novel clinical trial, which applies precision medicine to severe asthma treatment, reached a major milestone with the opening of recruitment and screening at two study site locations.
